@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix pfh: . @prefix geneProductOf: . @prefix hasAgent: . @prefix RNA: . @prefix hgnc: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0005525 . sub:_2 geneProductOf: pfh:RAS%20Family; a Protein: . sub:_3 geneProductOf: hgnc:3665; a RNA: . sub:_4 occursIn: species:9606; rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "gtp(p(PFH:\"RAS Family\")) -> r(HGNC:FGF1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_5 prov:value "These results link signaling pathways previously shown to be associated with cell proliferation (18) and cytoskeletal organization (29, 30) to growth factor gene activation and identify a cis element in FGF1 promoter 1D that can be defined as an SRE. This SRE is comprised of Ets and CArG sites. These sites are targets of regulation by divergent signaling pathways; Ets site target of Ras, Rac1, and Cdc42 regulation; and the CArG site target of de novo protein synthesis-independent cascade."; prov:wasQuotedFrom pubmed:10849427 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10849427; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:51.275+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }